Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Adinaide C. de Moura-Leal, João Macedo de Sousa, Heyder de Moura-Leal, Gabriela V. de Sousa, Airlane P. Alencar, Umbelina Soares Borges, Giovanny R. Pinto & Benedito B. da Silva. (2016) Evaluation of Ki-67 antigen expression in the vaginal epithelium of castrated female rats treated with raloxifene and tamoxifen: a comparative study. Gynecological Endocrinology 32:6, pages 453-456.
Read now
Read now
Stephen Martinkovich, Darshan Shah, Sonia Lobo Planey & John A Arnott. (2014) Selective estrogen receptor modulators: tissue specificity and clinical utility. Clinical Interventions in Aging 9, pages 1437-1452.
Read now
Read now
M. G. F. Sartori, P. C. Feldner$suffix/text()$suffix/text(), Z. I. K. Jarmy-Di Bella, R. Aquino Castro, E. C. Baracat, G. Rodrigues de Lima & M. J. B. Castello Girão. (2011) Sexual steroids in urogynecology. Climacteric 14:1, pages 5-14.
Read now
Read now
A. Nath & R. Sitruk-Ware. (2009) Pharmacology and clinical applications of selective estrogen receptor modulators. Climacteric 12:3, pages 188-205.
Read now
Read now
Alesse R. dos Santos, Pedro V. Lopes-Costa & Benedito B. da Silva. (2009) Vascular endothelial growth factor expression in the urethral epithelium of castrated adult female rats treated with tamoxifen. Gynecological Endocrinology 25:5, pages 282-286.
Read now
Read now
A. R. dos Santos, P. V. Lopes-Costa, C. S. Borges, C. G. Pires, J. M. de Sousa, J. C. de Castro & B. B. da Silva. (2008) Effects of raloxifene on the urethra of adult castrated female rats. Climacteric 11:6, pages 483-488.
Read now
Read now
Chang Bai, Osvaldo Flores & Azriel Schmidt. (2007) Opportunities for development of novel therapies targeting steroid hormone receptors. Expert Opinion on Drug Discovery 2:5, pages 725-737.
Read now
Read now
Articles from other publishers (43)
Recep Erin, Yeşim Bayoğlu Tekin, Özlem Aynaci, Kübra Baki Erin & Deniz Kulaksiz. (2022) Evaluation of the Pelvic Floor of Women with Breast Cancer Using Tamoxifen by Transperineal 3D Ultrasonography. The Journal of Obstetrics and Gynecology of India 72:6, pages 509-514.
Crossref
Crossref
Jon F. Pennycuff, Sameer Desale, Haijun Wang, Gongliang Zhang & Lee A. Richter. (2022) Prevalence of pelvic floor disorders, associations of endocrine therapy, and surgical intervention among breast cancer survivors. International Urogynecology Journal 33:9, pages 2421-2426.
Crossref
Crossref
Ethan M. FanPhilippe E. Zimmern. (2022) Challenges of Managing Lower Urinary Tract Symptoms in Women with Tamoxifen Use. Women's Health Reports 3:1, pages 430-436.
Crossref
Crossref
Luiz Gustavo Oliveira Brito, Glaucia Miranda Varella Pereira, Pamela Moalli, Oksana Shynlova, Jittima Manonai, Adi Yehuda Weintraub, Jan Deprest & Maria Augusta T. Bortolini. (2021) Age and/or postmenopausal status as risk factors for pelvic organ prolapse development: systematic review with meta-analysis. International Urogynecology Journal 33:1, pages 15-29.
Crossref
Crossref
Adi Y. Weintraub, Hannah Glinter & Naama Marcus-Braun. (2020) Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. International braz j urol 46:1, pages 5-14.
Crossref
Crossref
Hong-Xia Zheng, Yuan Zhao, Ying Xu, Zi-Jia Zhang, Jing-jing Zhu, Yuan-Fang Fan & Na Lin. (2019) Long-time qingyan formula extract treatment exerts estrogenic activities on reproductive tissues without side effects in ovariectomized rats and via active ER to ERE-independent gene regulation. Aging 11:12, pages 4032-4049.
Crossref
Crossref
Päivi Rahkola-Soisalo, Hanna Savolainen-Peltonen, Mika Gissler, Fabian Hoti, Pia Vattulainen, Olavi Ylikorkala & Tomi S. Mikkola. (2019) Postmenopausal hormone therapy is accompanied by elevated risk for uterine prolapse. Menopause 26:2, pages 140-144.
Crossref
Crossref
Ying Xu, Xin Li, Ting Chen, Ya‐kun Qu, Hong‐xia Zheng, Zi‐jia Zhang, Yuan Zhao & Na Lin. (2018)
Retracted
: Radix Paeoniae Alba increases serum estrogen level and up‐regulates estrogen receptor expression in uterus and vagina of immature/ovariectomized mice
. Phytotherapy Research 33:1, pages 117-129.
Crossref
Crossref
Ying Xu, Ting Chen, Xin Li, Ya-kun Qu, Jin-na An, Hong-xia Zheng, Zi-jia Zhang & Na Lin. (2016) Salvia miltiorrhiza bunge increases estrogen level without side effects on reproductive tissues in immature/ovariectomized mice. Aging 9:1, pages 156-172.
Crossref
Crossref
Suzanne N. Landi, Kemi M. Doll, Jeannette T. Bensen, Laura Hendrix, Carey K. Anders, Jennifer M. Wu & Hazel B. Nichols. (2016) Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis. Cancer Causes & Control 27:11, pages 1325-1332.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
14
16
.
Ying Xu, Xiao-ping Ma, Jin-na An, Zi-jia Zhang, Jie Ding, Ya-kun Qu, Zhen-li Liu & Na Lin. (2015) RETRACTED ARTICLE: Short-time QiBaoMeiRan Formula Treatment Exerts Estrogenic Activities without Side Effects on Reproductive Tissues in Immature Mice. Scientific Reports 5:1.
Crossref
Crossref
David F. Archer, Bruce R. Carr, JoAnn V. Pinkerton, Hugh S. Taylor & Ginger D. Constantine. (2015) Effects of ospemifene on the female reproductive and urinary tracts. Menopause 22:7, pages 786-796.
Crossref
Crossref
Dzeufiet Djomeni Paul Désiré, Mengue Ngadena Yolande Sandrine, Bilanda Danielle Claude, Kameni Mireille, Aboubakar Oumarou Bibi-Farouck, Dimo Théophile & Kamtchouing Pierre. (2015) In vivo estrogenic-like activities of Gouania longipetala Hemsl. (Rhamnaceae) bark extracts in a post-menopause-like model of ovariectomized Wistar rats. Journal of Ethnopharmacology 168, pages 122-128.
Crossref
Crossref
Michael W. DeGregorio, Robert L. Zerbe & Gregory T. Wurz. (2014) Ospemifene: A first-in-class, non-hormonal selective estrogen receptor modulator approved for the treatment of dyspareunia associated with vulvar and vaginal atrophy. Steroids 90, pages 82-93.
Crossref
Crossref
Barry S. Komm & Sebastian Mirkin. (2014) An overview of current and emerging SERMs. The Journal of Steroid Biochemistry and Molecular Biology 143, pages 207-222.
Crossref
Crossref
James Simon, David Portman & R. Garn MabeyJr.Jr.. (2014) Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women. Maturitas 77:3, pages 274-281.
Crossref
Crossref
Lucio M.A. Cipullo, Cosimo Cosimato, Amelia Filippelli, Valeria Conti, Viviana Izzo, Fulvio Zullo & Maurizio Guida. (2014) Pharmacological approach to overactive bladder and urge urinary incontinence in women: an overview. European Journal of Obstetrics & Gynecology and Reproductive Biology 174, pages 27-34.
Crossref
Crossref
Margery L.S. Gass & Sobia Khan. 2013. Osteoporosis. Osteoporosis
1805
1825
.
Alesse R. dos Santos, Pedro V. Lopes-Costa, José A. Gontijo & Benedito B. da Silva. (2012) Effect of tamoxifen on extracellular signal-regulated kinases in the urethra of castrated female rats. European Journal of Obstetrics & Gynecology and Reproductive Biology 164:1, pages 102-104.
Crossref
Crossref
Steven R. Goldstein, Harjit Pal Bhattoa, Patrick Neven, David A. Cox, Sherie A. Dowsett, Jahangir Alam, Adrien Sipos & David Muram. (2012) Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass. Menopause 19:1, pages 41-47.
Crossref
Crossref
Shayne Cox GadGregory T. Wurz & Michael W. DeGregorio. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Stefan Nilsson, Konrad F. Koehler & Jan-Åke Gustafsson. (2011) Development of subtype-selective oestrogen receptor-based therapeutics. Nature Reviews Drug Discovery 10:10, pages 778-792.
Crossref
Crossref
Michael A. Bolognese. (2010) SERMs and SERMs with estrogen for postmenopausal osteoporosis. Reviews in Endocrine and Metabolic Disorders 11:4, pages 253-259.
Crossref
Crossref
JoAnn V. Pinkerton & Steven R. Goldstein. (2010) Endometrial safety. Menopause 17:3, pages 642-653.
Crossref
Crossref
Azin Shahryarinejad, Thomas R. Gardner, J. Mark Cline, William N. Levine, Haley A. Bunting, Michael D. Brodman, Charles J. Ascher-Walsh, Richard J. Scotti & Michael D. Vardy. (2010) Effect of hormone replacement and selective estrogen receptor modulators (SERMs) on the biomechanics and biochemistry of pelvic support ligaments in the cynomolgus monkey (Macaca fascicularis). American Journal of Obstetrics and Gynecology 202:5, pages 485.e1-485.e9.
Crossref
Crossref
David F. Archer, JoAnn V. Pinkerton, Wulf H. Utian, José C. Menegoci, Tobie J. de Villiers, Chui Kin Yuen, Amy B. Levine, Arkadi A. Chines & Ginger D. Constantine. (2009) Bazedoxifene, a selective estrogen receptor modulator. Menopause 16:6, pages 1109-1115.
Crossref
Crossref
Lubna Pal. (2009) Pelvic Organ Prolapse and Relationship with Skeletal Integrity. Women's Health 5:3, pages 325-333.
Crossref
Crossref
Sara L. Jackson & Stephan D. Fihn. (2009) Exogenous Estrogen and Urinary Incontinence. The Journal of Urology 181:5, pages 1989-1991.
Crossref
Crossref
Kozo Hirai & Hiroshi Tsuda. (2009) Estrogen and urinary incontinence. International Journal of Urology 16:1, pages 45-48.
Crossref
Crossref
Armando Delmanto, Jorge Nahas-Neto, Eliana A.P. Nahas, Maria Luiza C.S. de Oliveira, Cesar E. Fernandes & Paulo Traiman. (2008) Effect of raloxifene on the vaginal epithelium of postmenopausal women. European Journal of Obstetrics & Gynecology and Reproductive Biology 139:2, pages 187-192.
Crossref
Crossref
Kavirach Tantiwongse, Thomas M. Fandel, Guifang Wang, Benjamin N. Breyer, Thomas J. Walsh, Anthony J. Bella & Tom F. Lue. (2008) The potential of hormones and selective oestrogen receptor modulators in preventing voiding dysfunction in rats. BJU International 102:2, pages 242-246.
Crossref
Crossref
T Hertrampf, J Seibel, U Laudenbach, K H Fritzemeier & P Diel. (2008) Analysis of the effects of oestrogen receptor α (ERα)- and ERβ-selective ligands given in combination to ovariectomized rats. British Journal of Pharmacology 153:7, pages 1432-1437.
Crossref
Crossref
Xavier Gamé, Julien Allard, Ghislaine Escourrou, Pierre Gourdy, Ivan Tack, Pascal Rischmann, Jean-François Arnal & Bernard Malavaud. (2008) Estradiol increases urethral tone through the local inhibition of neuronal nitric oxide synthase expression. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 294:3, pages R851-R857.
Crossref
Crossref
Wendy Shelly, Michael W. Draper, Venkatesh Krishnan, Mayme Wong & Robert B. Jaffe. (2008) Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings. Obstetrical & Gynecological Survey 63:3, pages 163-181.
Crossref
Crossref
Alesse Ribeiro dos Santos, Pedro Vitor Lopes-Costa, Júlio César Dias de Castro, Igor Cardoso Campos, Rafael Soares Borges, Cleicilene Gomes Pires, Karina Oliveira Drumond, Airlane Pereira Alencar & Benedito Borges da Silva. (2008) Morphometric analysis of the urethra of castrated female rats treated with tamoxifen. Maturitas 59:3, pages 275-280.
Crossref
Crossref
H. Rozenbaum. (2008) Moduladores selectivos de los receptores de estrógenos (SERM). EMC - Ginecología-Obstetricia 44:2, pages 1-8.
Crossref
Crossref
H. Rozenbaum. (2008) « Selective estrogen receptor modulators » (SERM). EMC - Gynécologie 3:1, pages 1-7.
Crossref
Crossref
Guillermo Rimoldi, Julie Christoffel, Dana Seidlova-Wuttke, Hubertus Jarry & Wolfgang Wuttke. (2007) Effects of Chronic Genistein Treatment in Mammary Gland, Uterus, and Vagina. Environmental Health Perspectives 115:Suppl 1, pages 62-68.
Crossref
Crossref
T. Hertrampf, M.J. Gruca, J. Seibel, U. Laudenbach, K.H. Fritzemeier & P. Diel. (2007) The bone-protective effect of the phytoestrogen genistein is mediated via ERα-dependent mechanisms and strongly enhanced by physical activity. Bone 40:6, pages 1529-1535.
Crossref
Crossref
Sabine Rehm, Henk A. Solleveld, Samm T. Portelli & Patrick J. Wier. (2007) Histologic changes in ovary, uterus, vagina, and mammary gland of mature beagle dogs treated with the SERM idoxifene. Birth Defects Research Part B: Developmental and Reproductive Toxicology 80:3, pages 225-232.
Crossref
Crossref
FELICIA COSMAN & ROBERT LINDSAY. 2007. Treatment of the Postmenopausal Woman. Treatment of the Postmenopausal Woman
837
845
.
Jens Hoffmann & Anette Sommer. 2007. Cancer. Cancer
19
82
.